You are in fact wrong. PIP couldn't come up w the necessary finances. Oddly enough, it was in the aborted merger agreement that SIGA promised to negotiate for a product license in good faith. That's one thing that makes the whole PIP lawsuit stink.
Ignore this idiot. He's a short who thinks he can convince people to sell their stock by either writing generalities or by flat out lying. It's about time he joins the other resident annoyances. IGNORE
Go short -- you wrote that "Siga had years ahead of them" -- which is not the best English, is it, Short? Siga's drug is still years ahead of Chimerix's CMX-001 in terms of the smallpox market, which is all that matters on this board.
You keep blasting Siga, which is why I think you are short, and why you're now on ignore. No shareholder would spend so much time knocking his own stock on a public message board.
Oh for God's sake! That is a scurrilous post. Their positive results were this: "CMX001 to Prevent Cytomegalovirus Disease in Hematopoietic-Cell Transplantation." That has nothing to do with smallpox, and nothing to do with CMXR's chances of sharing in further stockpiling of anti-smallpox, and NOTHING TO DO WITH SIGA. SIGA is still years ahead of CMRX in anti-SMALLPOX results. Golong must have goneshort.